Dianthus Therapeutics, Inc. ( (DNTH) ) has released its Q3 earnings. Here is a breakdown of the information Dianthus Therapeutics, Inc.
Initiation of a single, two-part, pivotal Phase 3 trial of DNTH103 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) anticipated by ...
A rumor that food company Land O'Lakes had announced a return to its previous logo featuring a kneeling Indigenous woman on its packaging circulated online in October 2024. A Facebook post ...